Abstract
Sirolimus coated balloon (SCB) is a potential treatment option for peripheral arterial occlusive disease (PAOD). However, clinical data for this novel treatment for PAOD are lacking. We present the 24 months RESULTS of the first-in-human study of MagicTouch PTA SCB for treatment of PAOD for both femoropopliteal and below the knee arteries (BTK).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
